SCHEMBL6716155

SCHEMBL6716155

COCOc1c(C)cc(Br)cc1C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
PTPN1 P18031 1/20 0.38
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PKM P14618 1/20 0.33
MAPT P10636 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
FAAH O00519 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
ACLY P53396 1/20 0.31
SCN4A P35499 2/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19381521 0.90 MAPT (0.39) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL31533184 0.87 POLB (0.43) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL17291956 0.84 PTGDR2 (0.35) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL13116219 0.83 NQO2 (0.36) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL26081261 0.82 KMT2A (0.40) KMT2AMEN1KDM4EPTPN1MAPT
SCHEMBL8417929 0.81 KMT2A (0.49) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL21483559 0.79 SCN4A (0.36) CYP1A2CYP2D6PTPN1BCHEACHE
SCHEMBL8564216 0.79 KMT2A (0.41) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL6543977 0.78 PTPN1 (0.41) KMT2AMEN1KDM4EALDH1A1PTPN1
SCHEMBL12772147 0.78 MAPT (0.53) KMT2AMEN1KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 KMT2A 3611/4885MEN1 3916/4885KDM4E 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.